Delivering new malaria drugs through grassroots private sector.

OBJECTIVE: To demonstrate that micro-franchising system is an effective way of improving access to effective health care such as the introduction of first line antimalarias in populations living in underserved rural areas in Kenya. DESIGN: A descriptive study. SETTING: Child and family wellness (CFW) micro-franchised nurse run clinics in Kenya. RESULTS: In 2007, 39.3% of RDTs carried out were positive for malaria. All malaria positive (RDTs and microscopy) patients received artemether lumefantrine (AL) according to their weight in accordance with the Government approved treatment guidelines. During the same period a total of 3,248 community members were reached with malaria information, however, community expectations took longer to change as patients demanded AL even when the malaria diagnosis was negative. Initially, this led to the dispensing of other antimalarials to patients with malaria like symptoms even with a negative test. This demand decreased with more community education on the importance of the tests. Engaging the private sector though with challenges proved feasible and appropriate in accessing malaria treatment based on clinical diagnosis supported by RDTs to confirm the diagnosis instead of presumptive treatment based on fever. This led to a reduction of antimalarial prescriptions by more than 50%, implying better patient care, rational drug use as well as cost savings on malaria treatment. CONCLUSION: A micro-franchising system is an effective and sustainable way of improving access to effective health care by populations living in underserved rural areas of Africa. With appropriate supportive training and supervision, the system can adapt to changes in treatment guidelines and to new regimens.

Human immunodeficiency virus seropositivity in children aged six to eighty-four months at Kenyatta National Hospital

To determine the prevalence of the HIV seropositivity in general paediatric emergency admissions at Kenyatta National Hospital; 552 children were studied systematically for four months in 1991.A clinical history was taken and physical examination conducted. The HIV status was determined by use of organ Teknika's Vironostika viral lysate assay for initial two screenings and then a Behring enzygnost anti-HIV-1 synthetic peptide assays a confirmatory assay.Seventy (12.7) of all the children studied were HIV positive; the mean age of the HIV-positive children was 17.5 months while that of the total study population was 23.5 months. HIV seropositivity was not associated with history or parenteral injections. No haemophilia patient was recruited during the study period; and of all the 18 sicklers recruited; none was HIV positive despite multiple blood transfusions. The WHO paediatric Aids Case definition criteria had moderately low sensitivity (55.7); high specificity (85.9) and low positive predictive value (36.4). This was in agreement with observations noted in other studies in East and Central Africa